Publication
Signal Intensity Change on Unenhanced T1-Weighted Images in Dentate Nucleus Following Gadobenate Dimeglumine in Patients With and Without Previous Multiple Administrations of Gadodiamide
dc.contributor.author | Ramalho, J | |
dc.contributor.author | Semelka, RC | |
dc.contributor.author | AlObaidy, M | |
dc.contributor.author | Ramalho, M | |
dc.contributor.author | Nunes, RH | |
dc.contributor.author | Castillo, M | |
dc.date.accessioned | 2018-03-15T15:34:26Z | |
dc.date.available | 2018-03-15T15:34:26Z | |
dc.date.issued | 2016-11 | |
dc.description.abstract | OBJECTIVES: To evaluate the impact of previous administration of gadodiamide and neural tissue gadolinium deposition in patients who received gadobenate dimeglumine. METHODS: Our population included 62 patients who underwent at least three administrations of gadobenate dimeglumine, plus an additional contrast-enhanced last MRI for reference, divided into two groups: group 1, patients who in addition to gadobenate dimeglumine administrations had prior exposure to multiple doses of gadodiamide; group 2, patients without previous exposure to other gadolinium-based contrast agent (GBCAs). Quantitative analysis was performed on the first and last gadobenate dimeglumine MRIs in both groups. Dentate nucleus-to-middle cerebellar peduncle signal intensity ratios (DN/MCP) and relative change (RC) in signal over time were calculated and compared between groups using generalized additive model. RESULTS: Group 1 showed significant increase in baseline and follow-up DN/MCP compared to group 2 (p < 0.0001). The RC DN/MCP showed a non-statistically significant trend towards an increase in patients who underwent previous gadodiamide (p = 0.0735). CONCLUSION: There is increased T1 signal change over time in patients who underwent gadobenate dimeglumine and had received prior gadodiamide compared to those without known exposure to previous gadodiamide. A potentiating effect from prior gadodiamide on subsequent administered gadobenate dimeglumine may occur. KEY POINTS: • Neural gadolinium deposition is associated with multiple administrations of less stable GBCAs. • Less stable GBCA effect on subsequent more stable GBCA administrations is undetermined. • Significant increase of DN/MCP was seen in patients with previous gadodiamide exposure. • RC DN/MCP showed a non-significant increase in patients who received previous gadodiamide. • Potentiating effects from prior gadodiamide on subsequent administered gadobenate dimeglumine may occur. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Eur Radiol. 2016 Nov;26(11):4080-4088 | pt_PT |
dc.identifier.doi | 10.1007/s00330-016-4269-7 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/2953 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Springer Verlag | pt_PT |
dc.subject | Adult | pt_PT |
dc.subject | Aged | pt_PT |
dc.subject | Aged, 80 and over | pt_PT |
dc.subject | Cerebellar Nuclei | pt_PT |
dc.subject | Cerebellum | pt_PT |
dc.subject | Contrast Media | pt_PT |
dc.subject | Female | pt_PT |
dc.subject | Gadolinium | pt_PT |
dc.subject | Gadolinium DTPA | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Longitudinal Studies | pt_PT |
dc.subject | Magnetic Resonance Imaging | pt_PT |
dc.subject | Male | pt_PT |
dc.subject | Meglumine | pt_PT |
dc.subject | Middle Aged | pt_PT |
dc.subject | Organometallic Compounds | pt_PT |
dc.subject | CHLC IMA | pt_PT |
dc.title | Signal Intensity Change on Unenhanced T1-Weighted Images in Dentate Nucleus Following Gadobenate Dimeglumine in Patients With and Without Previous Multiple Administrations of Gadodiamide | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 4088 | pt_PT |
oaire.citation.issue | 11 | pt_PT |
oaire.citation.startPage | 4080 | pt_PT |
oaire.citation.title | European Radiology | pt_PT |
oaire.citation.volume | 26 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |